The Use of Muzolimine in Nephrotic Syndrome: Diuretic Effect and Tubular Functions

  • M. Bruno
  • C. Martini
  • M. Marangella
  • B. Fruttero
  • A. Tricerri
  • G. Sebastiani
  • F. Linari
Chapter
Part of the Developments in Nephrology book series (DINE, volume 18)

Abstract

Muzolimine (M) is a potent diuretic drug recently introduced into clinical use, which shows both high cieling and long acting properties (1,2). It has been held effective in hypertension and in oedematous syndromes from cardiac, hepatic and renal aetiology (3,4,5). This study was designed to evaluate the diuretic or any other effect on tubular transport in patients (pts) with oedema from nephrotic syndrome in course of diverse renal diseases.

Keywords

Cholesterol Urea Creatinine Citrate Glycine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1).
    Berg KJ, Jørstad S, Tromsdal A. Pharmaterapeutica, 1: 319–32, 1976.Google Scholar
  2. 2).
    Dal Canton A, Russo D, Gallo R, Conte G, Andreucci V. Brit Med J, 282: 595–8, 1981.CrossRefGoogle Scholar
  3. 3).
    Heinrich F, Loew D, Dycka J. Curr Med Res Opin, 4: 706–11, 1977.CrossRefGoogle Scholar
  4. 4).
    Brørs O, Fauchald P, Jacobsen S. Curr Med Res Opin, 6:431–36, 1980.PubMedCrossRefGoogle Scholar
  5. 5).
    Weisscheid E, Russendorf MG, Ritz E. Clin Nephrol, Vol 19, Suppl. No.l:S 50–3, 1983.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1987

Authors and Affiliations

  • M. Bruno
    • 1
  • C. Martini
    • 1
  • M. Marangella
    • 1
  • B. Fruttero
    • 1
  • A. Tricerri
    • 1
  • G. Sebastiani
    • 1
  • F. Linari
    • 1
  1. 1.Department of NephrologyMauriziano Umberto I HospitalTurinItaly

Personalised recommendations